NDC 82922-021 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-021
- Package NDCs from labels
- 82922-021-01
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PIRFENIDONE - Truemed Group LLC | Truemed Group LLC | 2022-08-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pirfenidone | PIRFENIDONE | Teva Pharmaceuticals, Inc. | cbbd14a4-b7e6-4147-9314-bb715dfb1a51 | 2024-10-01 | Warnings, Adverse reactions | D7NLD2JX7U |
| PIRFENIDONE | PIRFENIDONE | Novadoz Pharmaceuticals LLC | 741d1b9c-e281-4eca-b327-e25e82313006 | 2024-07-23 | Warnings, Adverse reactions | D7NLD2JX7U |
| PIRFENIDONE | PIRFENIDONE | Northstar Rx LLC | 5d0eee8c-dc7d-4444-8684-e9c9335291c8 | 2024-03-08 | Warnings, Adverse reactions | D7NLD2JX7U |
| Pirfenidone | PIRFENIDONE | Alembic Pharmaceuticals Inc. | 9214862e-9ef7-4370-856a-f5697978270a | 2023-12-06 | Warnings, Adverse reactions | D7NLD2JX7U |
| PIRFENIDONE | PIRFENIDONE | ScieGen Pharmaceuticals, Inc. | 1fbdb556-b164-4e0b-a95e-6004d50e3364 | 2023-11-09 | Warnings, Adverse reactions | D7NLD2JX7U |
| PIRFENIDONE | PIRFENIDONE | ScieGen Pharmaceuticals, Inc. | 155b948e-47f5-4741-8e82-2ed65ccfab7d | 2023-11-08 | Warnings, Adverse reactions | D7NLD2JX7U |
| Pirfenidone | PIRFENIDONE | Camber Pharmaceuticals, Inc. | a7f3485e-9dcc-45db-9b9c-74c70e22c4bb | 2023-05-11 | Warnings, Adverse reactions | D7NLD2JX7U |
| Pirfenidone | PIRFENIDONE | Sandoz Inc | 7f5f7cc9-394e-4da0-87eb-84cfff9707a3 | 2023-04-30 | Warnings, Adverse reactions | D7NLD2JX7U |
| Pirfenidone | PIRFENIDONE | Amneal Pharmaceuticals NY LLC | a235768d-d26d-4ded-ae75-53e93310ff6a | 2023-04-10 | Warnings, Adverse reactions | D7NLD2JX7U |
| Pirfenidone | PIRFENIDONE | Alembic Pharmaceuticals Limited | 6e4f991a-c9e3-4121-97d0-d07954f17336 | 2023-03-30 | Warnings, Adverse reactions | D7NLD2JX7U |
| PIRFENIDONE | PIRFENIDONE | EXELAN PHARMACEUTICALS INC. | 1709582c-9975-4dc1-8181-2501ee670eef | 2023-01-20 | Warnings, Adverse reactions | D7NLD2JX7U |
| ed8b6a2d-20bb-6ef0-e053-2995a90a1ead | e5e6899f-7f2a-67e8-e053-2a95a90ad161 | 2022-11-15 | e5e6899f-7f2a-67e8-e053-2a95a90ad161 | |||
| Pirfenidone | PIRFENIDONE | Cipla USA Inc. | 1927bf5d-1ef3-4a36-8dac-dc0a45b72fec | 2022-08-26 | Warnings, Adverse reactions | D7NLD2JX7U |
| Pirfenidone | PIRFENIDONE | EXELAN PHARMACEUTICALS INC. | c171e4af-1619-4712-958f-ef96adfede37 | 2022-08-08 | Warnings, Adverse reactions | D7NLD2JX7U |
| PIRFENIDONE | PIRFENIDONE | Cipla USA Inc. | 16fca4fc-b641-4ee8-a2ee-a35189ce1f3b | 2022-08-03 | Warnings, Adverse reactions | D7NLD2JX7U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.